Função pulmonar em indivíduos pós COVID-19: uma revisão de escopo
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Tipo de documento: | Trabalho de conclusão de curso |
Idioma: | por |
Título da fonte: | Repositório Institucional da UFAM |
Texto Completo: | http://riu.ufam.edu.br/handle/prefix/6089 |
Resumo: | Introduction: COVID-19, caused by SARS-CoV-2, is a disease that mainly affects the respiratory tract, leaving it vulnerable and exposed to infections that compromise the pulmonary system. COVID-19 can leave multiple organ sequelae, ranging from physical and cognitive abnormalities to functional limitations. Objectives: To elucidate the impacts on lung function in post-COVID-19 individuals. Methods: Scope review developed according to the JBI methodology and the PRISMA-ScR recommendations were followed. The following were included: studies with moderate and severe post-COVID-19 patients, of both sexes, aged ≥ 18 years; studies that evaluated pulmonary function by pulmonary function tests such as spirometry and pulmonary diffusing capacity for carbon monoxide (DLCO); studies in any geographic and clinical context. Searches were carried out for studies published in the MEDLINE, LILACS, EMBASE and CINAHL databases, without time frame or language limitation. Studies were selected by two independent reviewers. Data extraction was performed using a tool developed by the reviewers themselves. Results: 13 studies were included in the review, with a total of 1373 participants, between 18 and 61 years of age, of both sexes. Most of the included studies were observational in design (11/13) and all 13 were published in English. The most used pulmonary function test was spirometry. The main ventilatory disorder found was restrictive. Conclusion: The impacts of COVID-19 on lung function mapped were mostly restrictive spirometry abnormalities and altered pulmonary gas diffusion. Most studies indicate that a significant proportion of COVID-19 survivors have impaired lung function between 3 and 12 months after hospital discharge. |
id |
UFAM-1_e5977f239d0e45def2c3b839209c0307 |
---|---|
oai_identifier_str |
oai:localhost:prefix/6089 |
network_acronym_str |
UFAM-1 |
network_name_str |
Repositório Institucional da UFAM |
repository_id_str |
|
spelling |
Função pulmonar em indivíduos pós COVID-19: uma revisão de escopoLung function in post-COVID-19 individuals: a scoping reviewCOVID-19SpirometryEspirometriaTestes de Função RespiratóriaSARS-CoV-2Respiratory Function TestsCIENCIAS DA SAUDECOVID-19 (Doença)Pulmões - InfecçõesTestes funcionais dos pulmõesIntroduction: COVID-19, caused by SARS-CoV-2, is a disease that mainly affects the respiratory tract, leaving it vulnerable and exposed to infections that compromise the pulmonary system. COVID-19 can leave multiple organ sequelae, ranging from physical and cognitive abnormalities to functional limitations. Objectives: To elucidate the impacts on lung function in post-COVID-19 individuals. Methods: Scope review developed according to the JBI methodology and the PRISMA-ScR recommendations were followed. The following were included: studies with moderate and severe post-COVID-19 patients, of both sexes, aged ≥ 18 years; studies that evaluated pulmonary function by pulmonary function tests such as spirometry and pulmonary diffusing capacity for carbon monoxide (DLCO); studies in any geographic and clinical context. Searches were carried out for studies published in the MEDLINE, LILACS, EMBASE and CINAHL databases, without time frame or language limitation. Studies were selected by two independent reviewers. Data extraction was performed using a tool developed by the reviewers themselves. Results: 13 studies were included in the review, with a total of 1373 participants, between 18 and 61 years of age, of both sexes. Most of the included studies were observational in design (11/13) and all 13 were published in English. The most used pulmonary function test was spirometry. The main ventilatory disorder found was restrictive. Conclusion: The impacts of COVID-19 on lung function mapped were mostly restrictive spirometry abnormalities and altered pulmonary gas diffusion. Most studies indicate that a significant proportion of COVID-19 survivors have impaired lung function between 3 and 12 months after hospital discharge.Introdução: A COVID-19, causada pelo SARS-CoV-2, é uma doença que atinge, principalmente, o trato respiratório deixando-o vulnerável e exposto a infecções que comprometem o sistema pulmonar. A COVID-19 pode deixar sequelas de múltiplos órgãos, que variam de anormalidades físicas e cognitivas até limitações funcionais. Objetivos: Elucidar os impactos na função pulmonar em indivíduos pós-COVID-19. Métodos: Revisão de escopo desenvolvida conforme a metodologia do JBI e as recomendações do PRISMA-ScR foram seguidas. Foram incluídos: estudos com pacientes pós-COVID-19 moderados e graves, de ambos os sexos, com idade ≥ 18 anos; estudos que avaliaram da função pulmonar por testes de função pulmonar como a espirometria e capacidade de difusão pulmonar para o monóxido de carbono (DLCO); estudos em qualquer contexto geográfico e clínico. Foram realizadas buscas por estudos publicados nos bancos de dados MEDLINE, LILACS, EMBASE e CINAHL, sem recorte temporal e nem limitação de idioma. Os estudos foram selecionados por dois revisores independentes. A extração dos dados foi realizada através de uma ferramenta elaborada pelos próprios revisores. Resultados: Foram incluídos na revisão 13 estudos, com um total de 1373 participantes, entre 18 e 61 anos de idade, de ambos os sexos. A maioria dos estudos incluídos eram de desenho observacional (11/13) e todos os 13 publicados em inglês. O teste de função pulmonar mais utilizado foi a espirometria. O principal distúrbio ventilatório encontrado foi o restritivo. Conclusão: Os impactos da COVID-19 na função pulmonar mapeados majoritariamente eram anormalidades espirométricas restritivas e alteração da difusão gasosa pulmonar. A maioria dos estudos apontam que uma proporção significativa dos sobreviventes de COVID-19 apresenta comprometimento na função pulmonar entre 3 e 12 meses após a alta hospitalar.5SimBrasilISB - Instituto de Saúde e Biotecnologia (Coari)Coari (AM)Fisioterapia - Bacharelado - CoariSilva, Thiago Santos dahttp://lattes.cnpq.br/4361231707356473Oliveira, Adriano Carvalho dehttp://lattes.cnpq.br/4721345186138074Braga, Johrdy Amilton da Costahttp://lattes.cnpq.br/3334053260618527https://orcid.org/ 0000-0001-8291-1470https://orcid.org/ 0000-0001-8291-1470https://orcid.org/ 0000-0001-8225-7974https://orcid.org/ 0000-0001-8225-7974Silva, Aurijonison Souza da2022-01-25T19:32:51Z2022-01-252022-01-25T19:32:51Z2021-11-18info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesishttp://riu.ufam.edu.br/handle/prefix/6089porALBU, Sergiu et al. O que está acontecendo após a covid-19 aguda? Características clínicas de pacientes em programa de reabilitação ambulatorial. NeuroRehabilitation , n. Pré-impressão, p. 1-12, 2021; BALDINI, Matías et al. Evaluation of the pulmonary function of patients with severe coronavirus 2019 disease three months after diagnosis. Medicina (Buenos Aires), v. 81, n. 5, 2021; BELLAN, Mattia et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA network open, v. 4, n. 1, p. e2036142-e2036142, 2021; BOUTELEUX, Benoit et al. Respiratory rehabilitation for Covid-19 related persistent dyspnoea: A one-year experience. Respiratory medicine, v. 189, p. 106648, 2021; CORTÉS-TELLES, Arturo et al. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respiratory Physiology & Neurobiology, v. 288, p. 103644, 2021; DARCIS, Gilles et al. Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. International Journal of Infectious Diseases, v. 109, p. 209-216, 2021; FAVERIO, Paola et al. Six-month pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study. medRxiv, 2021; FONSECA, Ana et al. Avaliação da função pulmonar em pacientes pós-COVID-19-quando e como devemos realizá-la?. Jornal Brasileiro de Pneumologia, v. 47, 2021; FORCE, ARDS Definition Task et al. Acute respiratory distress syndrome. Jama, v. 307, n. 23, p. 2526-2533, 2012; FUMAGALLI, Alessia et al. Pulmonary function in patients surviving to COVID-19 pneumonia. Infection, v. 49, n. 1, p. 153-157, 2021; GEORGE, Peter M.; WELLS, Athol U.; JENKINS, R. Gisli. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. The Lancet Respiratory Medicine, v. 8, n. 8, p. 807-815, 2020; GONZÁLEZ, Jessica et al. Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort. Chest, 2021; GUO, Tao et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA cardiology, v. 5, n. 7, p. 811-818, 2020; HELMS, Julie et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive care medicine, v. 46, n. 6, p. 1089-1098, 2020; HUANG, Chaolin et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, v. 395, n. 10223, p. 497-506, 2020. LINDAHL, Anna et al. Small airway function in Finnish COVID-19 survivors. Respiratory research, v. 22, n. 1, p. 1-5, 2021. LIU, Kai et al. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complementary therapies in clinical practice, v. 39, p. 101166, 2020; LOPEZ-ROMERO, S. et al. Symptoms and Pulmonary Function Improvement After 4 Months of Acute COVID 19 in a Mexican Population. In: TP117. TP117 COVID-19 PATHOPHYSIOLOGY AND MODELLING. American Thoracic Society, 2021. p. A4472-A4472.MAO, L. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. jamanetwork.com, 2020; MCDONALD, Lindsay T. Healing after COVID-19: are survivors at risk for pulmonary fibrosis? American Journal of Physiology-Lung Cellular and Molecular Physiology, v. 320, n. 2, p. L257-L265, 2021; MOORE, John B.; JUNE, Carl H. Cytokine release syndrome in severe COVID-19. Science, v. 368, n. 6490, p. 473-474, 2020; MUNN, Zachary et al. The development of software to support multiple systematic review types: the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI). JBI Evidence Implementation, v. 17, n. 1, p. 36-43, 2019; CHÉRREZ-OJEDA, Iván et al. Acompanhamento de pacientes após pneumonia COVID-19. Sequelas pulmonares. Revista Alergia de México,v. 67, n. 4, 2020. MCKITTERICK, Della John et al. International nursing students’ and new graduates’ experiences of transition to the nursing workforce: a scoping review protocol. JBI Evidence Synthesis, v. 19, n. 4, p. 874-882, 2021; RICHARDSON, Safiya et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. Jama, v. 323, n. 20, p. 2052-2059, 2020; SALEM, Ayad Mohammed et al. The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors. International Journal of General Medicine, v. 14, p. 3271, 2021; SOLANKI, Naisargee et al. ASSESSMENT OF PULMONARY FUNCTION OUTCOMES IN PATIENTS WITH COVID-19 SIX-WEEKS POST HOSPITAL DISCHARGE: A SINGLE-CENTER OBSERVATIONAL STUDY IN INDIA. Chest, v. 160, n. 4, p. A1753, 2021; SUNSERI, M. et al. Pulmonary Function After COVID-19: Preliminary Results of Survivorship Registry at 1 Month, 3 Months, and 6 Months. In: TP92. TP092 CLINICAL ADVANCES IN SARS-COV-2 AND COVID-19. American Thoracic Society, 2021. p. A3815-A3815; TRICCO, Andrea C. et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Annals of internal medicine, v. 169, n. 7, p. 467-473, 2018; WANG, Dawei et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, v. 323, n. 11, p. 1061-1069, 2020; ZHOU, Fei et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet, v. 395, n. 10229, p. 1054-1062, 2020.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFAMinstname:Universidade Federal do Amazonas (UFAM)instacron:UFAM2022-01-25T19:33:28Zoai:localhost:prefix/6089Repositório InstitucionalPUBhttp://riu.ufam.edu.br/oai/requestopendoar:2022-01-25T19:33:28Repositório Institucional da UFAM - Universidade Federal do Amazonas (UFAM)false |
dc.title.none.fl_str_mv |
Função pulmonar em indivíduos pós COVID-19: uma revisão de escopo Lung function in post-COVID-19 individuals: a scoping review |
title |
Função pulmonar em indivíduos pós COVID-19: uma revisão de escopo |
spellingShingle |
Função pulmonar em indivíduos pós COVID-19: uma revisão de escopo Silva, Aurijonison Souza da COVID-19 Spirometry Espirometria Testes de Função Respiratória SARS-CoV-2 Respiratory Function Tests CIENCIAS DA SAUDE COVID-19 (Doença) Pulmões - Infecções Testes funcionais dos pulmões |
title_short |
Função pulmonar em indivíduos pós COVID-19: uma revisão de escopo |
title_full |
Função pulmonar em indivíduos pós COVID-19: uma revisão de escopo |
title_fullStr |
Função pulmonar em indivíduos pós COVID-19: uma revisão de escopo |
title_full_unstemmed |
Função pulmonar em indivíduos pós COVID-19: uma revisão de escopo |
title_sort |
Função pulmonar em indivíduos pós COVID-19: uma revisão de escopo |
author |
Silva, Aurijonison Souza da |
author_facet |
Silva, Aurijonison Souza da |
author_role |
author |
dc.contributor.none.fl_str_mv |
Silva, Thiago Santos da http://lattes.cnpq.br/4361231707356473 Oliveira, Adriano Carvalho de http://lattes.cnpq.br/4721345186138074 Braga, Johrdy Amilton da Costa http://lattes.cnpq.br/3334053260618527 https://orcid.org/ 0000-0001-8291-1470 https://orcid.org/ 0000-0001-8291-1470 https://orcid.org/ 0000-0001-8225-7974 https://orcid.org/ 0000-0001-8225-7974 |
dc.contributor.author.fl_str_mv |
Silva, Aurijonison Souza da |
dc.subject.por.fl_str_mv |
COVID-19 Spirometry Espirometria Testes de Função Respiratória SARS-CoV-2 Respiratory Function Tests CIENCIAS DA SAUDE COVID-19 (Doença) Pulmões - Infecções Testes funcionais dos pulmões |
topic |
COVID-19 Spirometry Espirometria Testes de Função Respiratória SARS-CoV-2 Respiratory Function Tests CIENCIAS DA SAUDE COVID-19 (Doença) Pulmões - Infecções Testes funcionais dos pulmões |
description |
Introduction: COVID-19, caused by SARS-CoV-2, is a disease that mainly affects the respiratory tract, leaving it vulnerable and exposed to infections that compromise the pulmonary system. COVID-19 can leave multiple organ sequelae, ranging from physical and cognitive abnormalities to functional limitations. Objectives: To elucidate the impacts on lung function in post-COVID-19 individuals. Methods: Scope review developed according to the JBI methodology and the PRISMA-ScR recommendations were followed. The following were included: studies with moderate and severe post-COVID-19 patients, of both sexes, aged ≥ 18 years; studies that evaluated pulmonary function by pulmonary function tests such as spirometry and pulmonary diffusing capacity for carbon monoxide (DLCO); studies in any geographic and clinical context. Searches were carried out for studies published in the MEDLINE, LILACS, EMBASE and CINAHL databases, without time frame or language limitation. Studies were selected by two independent reviewers. Data extraction was performed using a tool developed by the reviewers themselves. Results: 13 studies were included in the review, with a total of 1373 participants, between 18 and 61 years of age, of both sexes. Most of the included studies were observational in design (11/13) and all 13 were published in English. The most used pulmonary function test was spirometry. The main ventilatory disorder found was restrictive. Conclusion: The impacts of COVID-19 on lung function mapped were mostly restrictive spirometry abnormalities and altered pulmonary gas diffusion. Most studies indicate that a significant proportion of COVID-19 survivors have impaired lung function between 3 and 12 months after hospital discharge. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-11-18 2022-01-25T19:32:51Z 2022-01-25 2022-01-25T19:32:51Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
format |
bachelorThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://riu.ufam.edu.br/handle/prefix/6089 |
url |
http://riu.ufam.edu.br/handle/prefix/6089 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
ALBU, Sergiu et al. O que está acontecendo após a covid-19 aguda? Características clínicas de pacientes em programa de reabilitação ambulatorial. NeuroRehabilitation , n. Pré-impressão, p. 1-12, 2021; BALDINI, Matías et al. Evaluation of the pulmonary function of patients with severe coronavirus 2019 disease three months after diagnosis. Medicina (Buenos Aires), v. 81, n. 5, 2021; BELLAN, Mattia et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA network open, v. 4, n. 1, p. e2036142-e2036142, 2021; BOUTELEUX, Benoit et al. Respiratory rehabilitation for Covid-19 related persistent dyspnoea: A one-year experience. Respiratory medicine, v. 189, p. 106648, 2021; CORTÉS-TELLES, Arturo et al. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respiratory Physiology & Neurobiology, v. 288, p. 103644, 2021; DARCIS, Gilles et al. Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. International Journal of Infectious Diseases, v. 109, p. 209-216, 2021; FAVERIO, Paola et al. Six-month pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study. medRxiv, 2021; FONSECA, Ana et al. Avaliação da função pulmonar em pacientes pós-COVID-19-quando e como devemos realizá-la?. Jornal Brasileiro de Pneumologia, v. 47, 2021; FORCE, ARDS Definition Task et al. Acute respiratory distress syndrome. Jama, v. 307, n. 23, p. 2526-2533, 2012; FUMAGALLI, Alessia et al. Pulmonary function in patients surviving to COVID-19 pneumonia. Infection, v. 49, n. 1, p. 153-157, 2021; GEORGE, Peter M.; WELLS, Athol U.; JENKINS, R. Gisli. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. The Lancet Respiratory Medicine, v. 8, n. 8, p. 807-815, 2020; GONZÁLEZ, Jessica et al. Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort. Chest, 2021; GUO, Tao et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA cardiology, v. 5, n. 7, p. 811-818, 2020; HELMS, Julie et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive care medicine, v. 46, n. 6, p. 1089-1098, 2020; HUANG, Chaolin et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, v. 395, n. 10223, p. 497-506, 2020. LINDAHL, Anna et al. Small airway function in Finnish COVID-19 survivors. Respiratory research, v. 22, n. 1, p. 1-5, 2021. LIU, Kai et al. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complementary therapies in clinical practice, v. 39, p. 101166, 2020; LOPEZ-ROMERO, S. et al. Symptoms and Pulmonary Function Improvement After 4 Months of Acute COVID 19 in a Mexican Population. In: TP117. TP117 COVID-19 PATHOPHYSIOLOGY AND MODELLING. American Thoracic Society, 2021. p. A4472-A4472.MAO, L. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. jamanetwork.com, 2020; MCDONALD, Lindsay T. Healing after COVID-19: are survivors at risk for pulmonary fibrosis? American Journal of Physiology-Lung Cellular and Molecular Physiology, v. 320, n. 2, p. L257-L265, 2021; MOORE, John B.; JUNE, Carl H. Cytokine release syndrome in severe COVID-19. Science, v. 368, n. 6490, p. 473-474, 2020; MUNN, Zachary et al. The development of software to support multiple systematic review types: the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI). JBI Evidence Implementation, v. 17, n. 1, p. 36-43, 2019; CHÉRREZ-OJEDA, Iván et al. Acompanhamento de pacientes após pneumonia COVID-19. Sequelas pulmonares. Revista Alergia de México,v. 67, n. 4, 2020. MCKITTERICK, Della John et al. International nursing students’ and new graduates’ experiences of transition to the nursing workforce: a scoping review protocol. JBI Evidence Synthesis, v. 19, n. 4, p. 874-882, 2021; RICHARDSON, Safiya et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. Jama, v. 323, n. 20, p. 2052-2059, 2020; SALEM, Ayad Mohammed et al. The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors. International Journal of General Medicine, v. 14, p. 3271, 2021; SOLANKI, Naisargee et al. ASSESSMENT OF PULMONARY FUNCTION OUTCOMES IN PATIENTS WITH COVID-19 SIX-WEEKS POST HOSPITAL DISCHARGE: A SINGLE-CENTER OBSERVATIONAL STUDY IN INDIA. Chest, v. 160, n. 4, p. A1753, 2021; SUNSERI, M. et al. Pulmonary Function After COVID-19: Preliminary Results of Survivorship Registry at 1 Month, 3 Months, and 6 Months. In: TP92. TP092 CLINICAL ADVANCES IN SARS-COV-2 AND COVID-19. American Thoracic Society, 2021. p. A3815-A3815; TRICCO, Andrea C. et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Annals of internal medicine, v. 169, n. 7, p. 467-473, 2018; WANG, Dawei et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, v. 323, n. 11, p. 1061-1069, 2020; ZHOU, Fei et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet, v. 395, n. 10229, p. 1054-1062, 2020. |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Brasil ISB - Instituto de Saúde e Biotecnologia (Coari) Coari (AM) Fisioterapia - Bacharelado - Coari |
publisher.none.fl_str_mv |
Brasil ISB - Instituto de Saúde e Biotecnologia (Coari) Coari (AM) Fisioterapia - Bacharelado - Coari |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFAM instname:Universidade Federal do Amazonas (UFAM) instacron:UFAM |
instname_str |
Universidade Federal do Amazonas (UFAM) |
instacron_str |
UFAM |
institution |
UFAM |
reponame_str |
Repositório Institucional da UFAM |
collection |
Repositório Institucional da UFAM |
repository.name.fl_str_mv |
Repositório Institucional da UFAM - Universidade Federal do Amazonas (UFAM) |
repository.mail.fl_str_mv |
|
_version_ |
1798061056487063552 |